CDKN2A and metabolic disease: The findings that p16INK4a-Cdk4-E2F3 signals modify mitochondrial numbers and activity are especially relevant considering the decline in muscle mitochondrial function during aging when metabolic diseases like T2D and mobility impairments are typically observed (73).